Novozymes A/S
NVZMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $113,174,943 | $103,048,566 | $97,669,787 | $151,014,895 |
| - Cash | $280,000 | $1,116,000 | $1,041,000 | $963,000 |
| + Debt | $1,796,800 | $7,733,000 | $411,000 | $482,000 |
| Enterprise Value | $114,691,743 | $109,665,566 | $97,039,787 | $150,533,895 |
| Revenue | $3,833,500 | $17,899,000 | $17,553,000 | $14,951,000 |
| % Growth | -78.6% | 2% | 17.4% | – |
| Gross Profit | $1,809,500 | $9,722,000 | $9,577,000 | $8,623,000 |
| % Margin | 47.2% | 54.3% | 54.6% | 57.7% |
| EBITDA | $8,071,006 | $5,471,000 | $6,115,000 | $5,400,000 |
| % Margin | 210.5% | 30.6% | 34.8% | 36.1% |
| Net Income | $305,800 | $3,024,000 | $3,676,000 | $3,146,000 |
| % Margin | 8% | 16.9% | 20.9% | 21% |
| EPS Diluted | 1.1 | 1.46 | 13.19 | 11.23 |
| % Growth | -24.7% | -88.9% | 17.5% | – |
| Operating Cash Flow | $1,019,900 | $4,152,000 | $4,006,000 | $4,062,000 |
| Capital Expenditures | -$359,800 | -$2,056,000 | -$2,890,000 | -$1,240,000 |
| Free Cash Flow | $660,100 | $2,096,000 | $1,116,000 | $2,822,000 |